Food Patterns, Inflammation Markers of Cardiovascular Disease Risk and Incidence of CVD

This study has been completed.
Sponsor:
Information provided by:
Skane University Hospital
ClinicalTrials.gov Identifier:
NCT01216228
First received: October 6, 2010
Last updated: NA
Last verified: October 2006
History: No changes posted
  Purpose

Health outcome studies should examine food patterns, because foods are consumed together and nutrients are metabolized jointly. To examine associations between food patterns and markers of systemic and vascular inflammation at baseline, in a population-based cohort in Malmö, Sweden, and after 13 years of follow-up food pattern associations with CVD incidence.


Condition
Cardiovascular Disease
Diet
Inflammation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Skane University Hospital:

Study Start Date: March 1991
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Sampling Method:   Non-Probability Sample
Study Population

The Malmö Diet and Cancer Cohort (MDC), a large-scale, population-based, prospective cohort study, was designed in the early 1990s to identify dietary and lifestyle risk factors related to the incidence of cancer. Men aged 46-73 years (n =11 063) and women aged 45-73 years (n = 17 035) living in Malmö, the third largest city in Sweden, at that time, were examinedinvited to participate. Baseline examinations took place at the MDC CentreCenter at the Skåne Malmö University Hospital in Malmö between March 1991 and October 1996.

Criteria

Inclusion Criteria:

  • The "cardiovascular sub-cohort" is a random sample (i.e., 50 percent) of those who joined from November 1991 to February 1994. This group underwent additional examinations to assess carotid arteriosclerosis by ultrasound (n = 6103) and donated blood after fasting (n = 5533).

Exclusion Criteria:

  • Subjects were excluded, either because they were using medication for diabetes mellitus or had previously been diagnosed as having diabetes mellitus.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Jan Nilsson, Professor, Lund University
ClinicalTrials.gov Identifier: NCT01216228     History of Changes
Other Study ID Numbers: MKC 2010-10-06
Study First Received: October 6, 2010
Last Updated: October 6, 2010
Health Authority: Sweden: Regional Ethical Review Board

Additional relevant MeSH terms:
Cardiovascular Diseases
Inflammation
Pathologic Processes

ClinicalTrials.gov processed this record on August 21, 2014